Recursion Pharma Raises $13M in Funding
Summary
Recursion Pharmaceuticals, a Salt Lake City, UT-based drug discovery company, raised $12.9m in Series A round of funding.Led by Chris Gibson, PhD, CEO, Recursion has built a proprietary drug discovery platform that combines high-throughput biology and automation with advances in Artificial Intelligence (AI).The company has already identified novel uses for known drugs, bioactive compounds, and shelved pharma assets in the space of rare genetic disease.The funding announcement follows the award of a grant from the National Institutes of Health to apply Recursion’s platform to diseases of aging.The company is also exploring both internal projects and partnerships in inflammation, infectious disease, oncology and diagnostics.
Funding
Amount
$13.0M
Total raised
Date
October 3, 2016
Announcement date
Investors
-
Lead investors
Company
http://www.recursionpharma.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected